18. Girard LP,Ceri H,Gibb AP,et al. MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis. Perit Dial Int,2010,30:652-656.
[2]
25. van den Braak N,van Belkum A,te Witt R,et al. Glycopeptide resistance amongst Staphylococcus spp. J Antimicrob Chemother,1998,42:673-675.
[3]
26. Sieradzki K,Villari P,Tomasz A. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother,1998,42:100-107.
2. Kloos WE. Natural populations of the genus Staphylococcus. Annu Rev Microbiol,1980,34:559-592.
[8]
3. Kloos WE,Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol,1975,30:381-385.
[9]
4. Anday EK,Talbot GH. Coagulase-negative Staphylococcus bacteremia--a rising threat in the newborn infant. Ann Clin Lab Sci,1985,15:246-251.
6. Fontela PS,Platt RW,Rocher I,et al. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units:a 6-year review. Am J Infect Control,2012,40:221-226.
9. Cercenado E. Update of antimicrobial resistance in Gram-positive microorganisms. Med Clin (Barc),2010,135 Suppl 3:10-15.
[15]
12. Rosenthal EJ. Epidemiology of septicaemia pathogens. Dtsch Med Wochenschr,2002,127:2435-2440.
[16]
13. Tornero E,Garcia-Oltra E,Garcia-Ramiro S,et al. Prosthetic joint infections due to Staphylococcus aureus and coagulase-negative staphylococci. Int J Artif Organs,2012,35:884-892.
[17]
14. Cremniter J,Slassi A,Quincampoix JC,et al. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol,2010,48:1428-1431.
[18]
15. Licking E. Getting a grip on bacterial slime. Business week,1999,78-79.
[19]
17. Mack D,Rohde H,Harris LG,et al. Biofilm formation in medical device-related infection. Int J Artif Organs,2006,29:343-359.
[20]
19. Ojo SK,Sargin BO,Esumeh FI. Plasmid curing analysis of antibiotic resistance in beta-lactamase producing Staphylococci from wounds and burns patients. Pak J Biol Sci,2014,17:130-133.
[21]
20. Wang Y,He T,Schwarz S,et al. Multidrug resistance gene cfr in methicillin-resistant coagulase-negative staphylococci from chickens,ducks,and pigs in China. Int J Med Microbiol,2013,303:84-87.
[22]
21. Cui L,Wang Y,Li Y,et al. Cfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans. PLoS One,2013,8:e57096.
[23]
22. Tomasz A,Nachman S,Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob Agents Chemother,1991,35:124-129.
[24]
23. Casapao AM,Leonard SN,Davis SL,et al. Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother,2013,57:4252-4259.
[25]
24. Park YJ,Jun Park J,Lee SO,et al. Low-level resistance to glycopeptides amongst staphylococcus species:surveillance in a university hospital and evaluation of a vancomycin screening agar. Diagn Microbiol Infect Dis,2001,41:155-159.
[26]
10. Nicoletti G,Bonfiglio G,Bartoloni A,et al. Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units:a 2-year comparison. Int J Antimicrob Agents,2000,15:265-269.
[27]
11. Stefani S,Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect,2003,9:1179-1186.
[28]
16. Farina N,Carpinelli L,Samudio M,et al. Clinically significant coagulase-negative staphylococci:most frequent species and virulence factors. Rev Chilena Infectol,2013,30:480-488.
